Mackall has also worked on cancer vaccines, immunomodulation therapy and bone marrow transplants. She received the Lila and Murray Gruber Award for Cancer Research in 2019, In 2018 Mackall was awarded $11.9 million to lead a clinical trial using genetically modified immune cells that will recognise proteins in leukemia.[12] The trial will be conducted at the Stanford Center for Cancer Cell Therapy.